
    
      The primary objective is to demonstrate the benefit of transcutaneous vagus nerve stimulation
      in obese subjects awaiting surgery. Secondary objectives include, among others, the risk
      factors related to obesity, systemic micro-inflammation, insulin and lipid profile.
    
  